Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal
Sun Pharma announces $11.75 billion acquisition of Organon, enhancing its global footprint in women’s health and biosimilars.
Source: The Hindu
Sun Pharma announces $11.75 billion acquisition of Organon, enhancing its global footprint in women’s health and biosimilars.
